Dongsheng Wang

3PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 18, 2020
Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients.

Xiaoling Xu, Mingfeng Han, Tiantian Li

|Nov 13, 2020
Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.

Xiaoling Xu, Mingfeng Han, Tiantian Li

|May 01, 2020
Effective treatment of severe COVID-19 patients with tocilizumab.

Xiaoling Xu, Mingfeng Han, Tiantian Li

Pageof 1